| International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma WD Travis, E Brambilla, M Noguchi, AG Nicholson, KR Geisinger, ... Journal of thoracic oncology 6 (2), 244-285, 2011 | 5894 | 2011 |
| Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label … T Mitsudomi, S Morita, Y Yatabe, S Negoro, I Okamoto, J Tsurutani, T Seto, ... The lancet oncology 11 (2), 121-128, 2010 | 4873 | 2010 |
| The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification WD Travis, E Brambilla, AG Nicholson, Y Yatabe, JHM Austin, ... Journal of thoracic oncology 10 (9), 1243-1260, 2015 | 4453 | 2015 |
| Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival J Takamizawa, H Konishi, K Yanagisawa, S Tomida, H Osada, H Endoh, ... Cancer research 64 (11), 3753-3756, 2004 | 3358 | 2004 |
| A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation Y Hayashita, H Osada, Y Tatematsu, H Yamada, K Yanagisawa, ... Cancer research 65 (21), 9628-9632, 2005 | 2135 | 2005 |
| Comprehensive genomic profiles of small cell lung cancer J George, JS Lim, SJ Jang, Y Cun, L Ozretić, G Kong, F Leenders, X Lu, ... Nature 524 (7563), 47-53, 2015 | 1956 | 2015 |
| Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications T Kosaka, Y Yatabe, H Endoh, H Kuwano, T Takahashi, T Mitsudomi Cancer research 64 (24), 8919-8923, 2004 | 1586 | 2004 |
| Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American … NI Lindeman, PT Cagle, DL Aisner, ME Arcila, MB Beasley, EH Bernicker, ... Archives of pathology & laboratory medicine 142 (3), 321-346, 2018 | 1467 | 2018 |
| EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors YL Choi, M Soda, Y Yamashita, T Ueno, J Takashima, T Nakajima, ... New England Journal of Medicine 363 (18), 1734-1739, 2010 | 1437 | 2010 |
| Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non–small-cell lung cancer with postoperative … T Mitsudomi, T Kosaka, H Endoh, Y Horio, T Hida, S Mori, S Hatooka, ... Journal of Clinical Oncology 23 (11), 2513-2520, 2005 | 1183 | 2005 |
| Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas T Hida, Y Yatabe, H Achiwa, H Muramatsu, K Kozaki, S Nakamura, ... Cancer research 58 (17), 3761-3764, 1998 | 1154 | 1998 |
| Reduced expression of Dicer associated with poor prognosis in lung cancer patients Y Karube, H Tanaka, H Osada, S Tomida, Y Tatematsu, K Yanagisawa, ... Cancer science 96 (2), 111-115, 2005 | 828 | 2005 |
| Analysis of epidermal growth factor receptor gene mutation in patients with non–small cell lung cancer and acquired resistance to gefitinib T Kosaka, Y Yatabe, H Endoh, K Yoshida, T Hida, M Tsuboi, H Tada, ... Clinical Cancer Research 12 (19), 5764-5769, 2006 | 753 | 2006 |
| Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor–activating mutations S Yano, W Wang, QI Li, K Matsumoto, H Sakurama, T Nakamura, H Ogino, ... Cancer research 68 (22), 9479-9487, 2008 | 743 | 2008 |
| Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer T Mitsudomi, Y Yatabe Cancer science 98 (12), 1817-1824, 2007 | 722 | 2007 |
| Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer T Mitsudomi, Y Yatabe The FEBS journal 277 (2), 301-308, 2010 | 692 | 2010 |
| PD-L1 immunohistochemistry comparability study in real-life clinical samples: results of blueprint phase 2 project MS Tsao, KM Kerr, M Kockx, MB Beasley, AC Borczuk, J Botling, ... Journal of Thoracic Oncology 13 (9), 1302-1311, 2018 | 683 | 2018 |
| A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer KP Ng, AM Hillmer, CTH Chuah, WC Juan, TK Ko, ASM Teo, ... Nature medicine 18 (4), 521-528, 2012 | 661 | 2012 |
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 645 | 2013 |
| The 2021 WHO classification of lung tumors: impact of advances since 2015 AG Nicholson, MS Tsao, MB Beasley, AC Borczuk, E Brambilla, ... Journal of Thoracic Oncology 17 (3), 362-387, 2022 | 634 | 2022 |
